Bank of Montreal
GH icon

Bank of Montreal’s Guardant Health GH Stock Holding History

Bank of Montreal’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.72M Buy
44,796
+17,881
+66% +$1.94M ﹤0.01% 1278
2026
Q1 		$2.49M Buy
26,915
+18,283
+212% +$1.84M ﹤0.01% 1570
2025
Q4 		$882K Buy
8,632
+426
+5% +$38.1K ﹤0.01% 2050
2025
Q3 		$513K Hold
8,206
– – ﹤0.01% 2259
2025
Q2 		$427K Buy
8,206
+88
+1% +$3.93K ﹤0.01% 2366
2025
Q1 		$346K Hold
8,118
– – ﹤0.01% 2419
2024
Q4 		$248K Buy
+8,118
New +$228K ﹤0.01% 2649
2024
Q3 		– Sell
-7,936
Closed -$236K – 3985
2024
Q2 		$236K Sell
7,936
-20,929
-73% -$487K ﹤0.01% 2891
2024
Q1 		$642K Buy
+28,865
New +$619K ﹤0.01% 2268
2023
Q4 		– Sell
-10,530
Closed -$367K – 4108
2023
Q3 		$367K Buy
10,530
+3,363
+47% +$118K ﹤0.01% 2663
2023
Q2 		$266K Buy
+7,167
New +$206K ﹤0.01% 3035
2022
Q4 		– Sell
-54,342
Closed -$3.06K – 4089
2022
Q3 		$3.06K Sell
54,342
-15,955
-23% -$819K ﹤0.01% 1606
2022
Q2 		$3.15K Buy
70,297
+64,375
+1,087% +$3.19M ﹤0.01% 1666
2022
Q1 		$397K Sell
5,922
-52,803
-90% -$3.61M ﹤0.01% 3005
2021
Q4 		$5.96M Sell
58,725
-48,545
-45% -$5.02M ﹤0.01% 1162
2021
Q3 		$13M Sell
107,270
-9,282
-8% -$1.1M 0.01% 1146
2021
Q2 		$14.9M Buy
116,552
+72,033
+162% +$9.69M 0.01% 1056
2021
Q1 		$7.1M Buy
44,519
+40,767
+1,087% +$6.16M ﹤0.01% 1179
2020
Q4 		$580K Buy
3,752
+51
+1% +$5.87K ﹤0.01% 2630
2020
Q3 		$406K Buy
3,701
+106
+3% +$9.7K ﹤0.01% 2419
2020
Q2 		$315K Sell
3,595
-3,193
-47% -$257K ﹤0.01% 2496
2020
Q1 		$442K Buy
6,788
+1,308
+24% +$100K ﹤0.01% 2034
2019
Q4 		$428K Sell
5,480
-606
-10% -$43.7K ﹤0.01% 2761
2019
Q3 		$388K Buy
6,086
+2,629
+76% +$232K ﹤0.01% 2546
2019
Q2 		$299K Buy
+3,457
New +$264K ﹤0.01% 2711

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Bank of Montreal's GH Position: Q2 2026 in Review

Bank of Montreal increased its Guardant Health (GH) stake by 66% in Q2 2026, buying an estimated $1.94M and bringing the position to 44,796 shares worth $6.72M. The position accounts for ﹤0.01% of the portfolio, ranked #1278.

Bank of Montreal first reported a position in GH in Q2 2019 and has held it in 25 quarters since. The position peaked at $14.9M in Q2 2021. 550 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Bank of Montreal held 44,796 shares of Guardant Health worth $6.72M as of Q2 2026.
  • Bank of Montreal bought 17,881 Guardant Health shares in Q2 2026, an estimated $1.94M.
  • Guardant Health made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #1278 holding.
  • Bank of Montreal first reported a position in Guardant Health in Q2 2019 and has held it in 25 quarters since.
  • Bank of Montreal's Guardant Health position peaked at $14.9M in Q2 2021.
  • 550 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.